首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.
【24h】

Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.

机译:残留的血小板因子V可确保患有严重先天性因子V缺乏症和轻度出血症状的患者产生凝血酶。

获取原文
获取原文并翻译 | 示例
           

摘要

Coagulation factor V (FV), present in plasma and platelets, is indispensable to thrombin formation, yet patients with undetectable plasma FV seldom experience major bleeding. We used thrombin generation assays to explore the role of platelet FV in 4 patients with severe congenital FV deficiency (3 with plasma FV clotting activity [FV:C] < 1%). When triggered with tissue factor (TF) concentrations up to 50pM, platelet-poor plasma (PPP) from the patients with undetectable plasma FV showed no thrombin generation, whereas platelet-rich plasma (PRP) formed thrombin already at 1 to 5pM of TF. Thrombin generation in PRP from the FV-deficient patients was enhanced to near-normal levels by platelet activators (collagen or Ca(2+)-ionophore) and could be completely suppressed by specific FV inhibitors, suggesting FV dependence. Accordingly, platelet FV antigen and activity were measurable in all FV-deficient patients and platelet FVa could be visualized by Western blotting. Normalization of the tissue factor pathway inhibitor (TFPI) level, which is physiologically low in FV-deficient plasma, almost completely abolished thrombin generation in PRP from the FV-deficient patients. In conclusion, patients with undetectable plasma FV may contain functional FV in their platelets. In combination with low TFPI level, residual platelet FV allows sufficient thrombin generation to rescue these patients from fatal bleeding.
机译:血浆和血小板中存在的凝血因子V(FV)对于凝血酶形成是必不可少的,但是血浆FV不可检测的患者很少会出现大出血。我们使用凝血酶生成测定法探讨血小板FV在4例严重先天性FV缺乏症(3例血浆FV凝血活性[FV:C] <1%)中的作用。当血浆因子FV浓度高达50pM触发时,血浆FV不可检测的贫血小板血浆(PPP)不会产生凝血酶,而富含血小板的血浆(PRP)在TF的1至5pM时已形成凝血酶。血小板活化剂(胶原蛋白或Ca(2 +)-离子载体)将FV缺乏症患者的PRP中的凝血酶生成提高至接近正常水平,并且可能被特定的FV抑制剂完全抑制,表明FV依赖性。因此,在所有FV缺陷患者中均可测量血小板FV抗原和活性,并且可以通过蛋白质印迹法观察血小板FVa。组织因子途径抑制剂(TFPI)水平的正常化(在FV缺乏的血浆中在生理上较低)几乎完全消除了FV缺乏的患者在PRP中产生的凝血酶。总之,血浆FV检测不到的患者的血小板中可能含有功能性FV。结合低TFPI水平,残留的血小板FV可以产生足够的凝血酶,以挽救这些患者的致命性出血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号